CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Macrolanedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01308853
NCT01308853N/ACompleted

An Open, Multi-center Study Evaluating Treatment Procedure, Efficacy and Safety of Macrolane VRF30 for Enhancement of the Shape and Fullness of the Female Breast

Galderma R&D·interventional·Posted Mar 4, 2011·Updated Sep 28, 2022

In Brief

A clinical study evaluating Macrolane for Breast Enhancement. Completed, enrolled 24 participants.

Detailed Summary

The study evaluates treatment procedure, efficacy and safety of Macrolane for female breast enhancement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 4, 2011
Enrollment StartFeb 1, 2007
Primary CompletionFeb 1, 2008
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 15.3 years ago

Interventions

Macrolanedevice

Device: Macrolane Treatment: Initial injection (incl touch-up) of a maximum of 120 ml/breast.